Nicola Carandente joined Bormioli Pharma in 2019 as Purchase Director and was promoted to Group Sales Director in September 2021. Prior to joining the company, he served as Divisional Purchasing Manager and EMEA Raw Materials Commodity Manager at Brembo S.p.A. for four years.
He holds a Master’s Degree in Industrial Engineering and Business Management from Università degli Studi di Napoli Federico II, and an Executive Master’s in Business Administration (EMBA) from SDA Bocconi. Additionally, he completed courses at the Frankfurt School of Finance & Management, focusing on Global Economics, Markets, and Institutions.
Dr. Jokinen is a co-founder of DelSiTech and Chief Scientific Officer of in the company. In addition, he is a Principal Lecturer in chemical and biochemical engineering at the Turku University of Applied Sciences. He has over 20 years R&D experience in silica-based biomaterials. Dr. Jokinen holds a Doctor of Science in Technology and has a position as Adjunct Professor in Medical Biomaterials at Åbo Akademi University, Turku, Finland.
Dr. René Holm is a professor in pharmaceutical physical chemistry at the University of Southern Denmark. After receiving Master and PhD degree in pharmaceutics from the University of Copenhagen, Denmark, in 2002, he started his carrier in the pharmaceutical industry at H.Lundbeck in 2001 and changed to Janssen in 2016. Dr. Holm has worked within pharmaceutical development, formulations for non-clinical testing in drug discovery, physical chemistry and material science covering both small and large molecules. In 2021 Dr. Holm engaged into a carrier change and became a full professor. Dr. Holm is (co-) author of more than 240 original articles in peer-reviewed journals and book chapters in the field of biopharmaceutics, preformulation, formulation and physical pharmacy and book chapters and is co-inventor on 19 published patents.
Dr. Peter Markland is a Pharmaceutical scientist with over 20 years of experience in drug delivery research, technology, and biomaterials development. His expertise includes directing internal drug delivery research and product development teams, and evaluating external delivery technologies. Dr Markland has also been involved in program management and marketing for novel, controlled release dosage forms and have experience in formulation development of a wide variety of drugs for various routes of administration.
Dr. Frederic Dargelas is the Director, Head of Business Development and Alliance Management of DelSiTech. He joined the company in 2019. Dr. Dargelas is a business development and R&D veteran with almost 20 years of experience in the pharma and biotech industry. Previously, he held managing positions at diverse international companies such as GSK and Orion Pharma. Dr. Dargelas holds a PhD in Physical Chemistry of Polymers and an MBA.
Dr. Loutjie Coetzee is the MetOptima Product Manager at Draslovka, and is based in South Africa.
Loutjie has over 16 years of experience in the minerals processing industry, specializing in advanced process control.
He holds a PhD in Electronic Engineering from The University of Pretoria where he completed his doctoral thesis on predictive control of closed run-of-mine ore milling circuits. Loutjie spent several years at Mintek and served as a guest lecturer at The University of Pretoria before joining Draslovka in 2024.
Education
• Business Management Saarland University, Saarbrücken
Professional experience
• 1997 – 2000
MLP AG – Financial Consultant
• 2000 – 2007
Daimler Financial Services AG – Various functions with time abroad (2001 – 2007) in
the USA at the Companies Daimler Truck Financial and Chrysler Financial
• 2007 – 2009
Mercedes Benz AG in Stuttgart, Director for Private and Corporate Business
• 2009 – 2012
Mercedes Benz AG in Stuttgart, Member of the Board for Private and Corporate
Business
• 2012 – 2017
Managing Director at Volkswagen Bank GmbH in Braunschweig
• 2017 – 2019
Managing Director at Volkswagen Leasing GmbH in Braunschweig
• 2019 – 2021
CEO & President VW Credit Inc. in USA
• from 1st October 2021 – CSO Volkswagen Financial Services in Braunschweig
